A comprehensive RNA editome reveals that edited Azin1 partners with DDX1 to enable hematopoietic stem cell differentiation

Fengjiao Wang 1, Jiahuan He 2, Siqi Liu 2, Ai Gao 1, Liu Yang 1, Guohuan Sun 1, Wanqiu Ding 3, Chuan-Yun Li 3, Fanglin Gou 1, Manman He 2, Fang Wang 2, Xiaoshuang Wang 2, Xiangnan Zhao 1, Ping Zhu 1 4, Sha Hao 1 4, Yanni Ma 2, Hui Cheng 1 4, Jia Yu 1 2, Tao Cheng 1 4

 

Blood.2021 Nov 18;138(20):1939-1952. doi: 10.1182/blood.2021011314.

PMID: 34388251

 

Abstract

Adenosine-to-inosine RNA editing and the catalyzing enzyme adenosine deaminase are both essential for hematopoietic development and differentiation. However, the RNA editome during hematopoiesis and the underlying mechanisms are poorly defined. Here, we sorted 12 murine adult hematopoietic cell populations at different stages and identified 30 796 editing sites through RNA sequencing. The dynamic landscape of the RNA editome comprises stage- and group-specific and stable editing patterns, but undergoes significant changes during lineage commitment. Notably, we found that antizyme inhibitor 1 (Azin1) was highly edited in hematopoietic stem and progenitor cells (HSPCs). Azin1 editing results in an amino acid change to induce Azin1 protein (AZI) translocation to the nucleus, enhanced AZI binding affinity for DEAD box polypeptide 1 to alter the chromatin distribution of the latter, and altered expression of multiple hematopoietic regulators that ultimately promote HSPC differentiation. Our findings have delineated an essential role for Azin1 RNA editing in hematopoietic cells, and our data set is a valuable resource for studying RNA editing on a more general basis.